Clinical Trial Update: Bromocriptine for Patients With Schizophrenia and Prediabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating bromocriptine for patients with schizophrenia and prediabetes, sponsored by the VA Pittsburgh Healthcare System. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Schizophrenia

Drugs mentioned

• Bromocriptine (bromocriptine)

Snippet

Sponsor: VA Pittsburgh Healthcare System | Conditions: Schizophrenia, PreDiabetes | Phase 4 | Status: NOT_YET_RECRUITING